“A Punch in the Gut”: After Years of Waiting, Many Opioid Victims Will Be Shut Out of Purdue Settlement

Purdue Pharma's $7.4 billion bankruptcy plan, approved in 2024, excludes tens of thousands of opioid victims who originally filed claims, including Mary Jannotta and her family, whose son died from an overdose. The new settlement slashes payments, imposes stricter eligibility requirements, and removes the option to use sworn affidavits to prove Purdue drug use, impacting victims like those who lost loved ones to overdoses.